Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
- Status
- COMPLETED
- Phase
- PHASE1
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
- Status
- TERMINATED
- Phase
- PHASE3